Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc News Story

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.72m
Position in Universe th / 6846

BRIEF-Dova Pharmaceuticals Announces U.S. FDA Approval Of Doptelet

Mon 21st May, 2018 6:01pm
May 21 (Reuters) - Dova Pharmaceuticals Inc  DOVA.O :
    * DOVA PHARMACEUTICALS ANNOUNCES U.S. FDA APPROVAL OF
DOPTELET®
(AVATROMBOPAG)
    * DOVA PHARMACEUTICALS INC - POSITIONED TO LAUNCH DOPTELET
IN JUNE

Source text for Eikon:  ID:nGNX457Hh8 
Further company coverage:  DOVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.